SAN DIEGO, January 17, 2025--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on January 13, 2025, the Compensation Committee of Acadia’s Board of Directors (the "Committee ...

Your message was sent. You'll receive a response shortly. Redesigned for 2024, the GMC Acadia grew in size to be more comparable with the Chevrolet Traverse with which it shares an underlying ...

After hours: February 3 at 4:23:24 PM EST Loading Chart for ACAD ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

After hours: January 31 at 6:12:24 p.m. EST ...

Updated specific recommendations are also provided for cutaneous, neuropsychiatric and haematological disease, SLE-associated antiphospholipid syndrome, kidney protection, as well as preventative ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

Proliferative lupus nephritis (LN) is the most common severe organ-threatening manifestation of systemic lupus erythematosus (SLE). The goal of treatment is to preserve kidney function and avoid the ...